Outlook Therapeutics, Inc.(OTLK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OTLK Outlook Therapeutics, Inc.

休市中 08-23 16:00:00 EDT

7.53

+0.36

+5.02%

盘后7.53

+0.000.00%

19:55 EDT

最高7.89	最低7.15	成交量17.91万
今开7.19	昨收7.17	日振幅10.32%
总市值1.78亿	流通市值8,974万	总股本2,366万
成交额135.59万	换手率1.50%	流通股本1,192万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"OTLK","market":"US","secType":"STK","nameCN":"Outlook Therapeutics, Inc.","latestPrice":7.53,"timestamp":1724443200000,"preClose":7.17,"halted":0,"volume":179082,"hourTrading":{"tag":"盘后","latestPrice":7.53,"preClose":7.53,"latestTime":"19:55 EDT","volume":979,"amount":7374.73,"timestamp":1724457337650},"delay":0,"floatShares":11917546,"shares":23655636,"eps":-5.926963,"marketStatus":"休市中","marketStatusCode":7,"change":0.36,"latestTime":"08-23 16:00:00 EDT","open":7.19,"high":7.89,"low":7.15,"amount":1355932.256904,"amplitude":0.103208,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.926963,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"adjPreClose":7.17,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":7.22,"preClose":7.17,"latestTime":"09:26 EDT","volume":55,"amount":396.850003,"timestamp":1724419580885},"postHourTrading":{"tag":"盘后","latestPrice":7.53,"preClose":7.53,"latestTime":"19:55 EDT","volume":979,"amount":7374.73,"timestamp":1724457337650},"volumeRatio":1.0246478035284996,"impliedVol":0.6193,"impliedVolPercentile":0.2111},"requestUrl":"/m/hq/s/OTLK/tweets","defaultTab":"tweets","newsList":[{"id":"2461830873","title":"Outlook Therapeutics, Inc.2024财年第二财季实现净利润44.41百万美元，同比增加314.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461830873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461830873?lang=zh_cn&edition=full","pubTime":"2024-08-22 00:00","pubTimestamp":1724256041,"startTime":"0","endTime":"0","summary":"8月22日，Outlook Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为44.41百万美元，同比增加314.75%；其中营业收入为0.00美元，每股基本收益为1.91美元。从资产负债表来看，Outlook Therapeutics, Inc.总负债1.31亿美元，其中短期债务32.46百万美元，资产负债比为35.95，流动比率为1.08。机构评级：截至2024年8月22日，当前有7家机构对Outlook Therapeutics, Inc.目标价做出预测，其中目标均价为37.43美元，其中最低目标价为25.00美元，最高目标价为53.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082200014395b07ff7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082200014395b07ff7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","LENZ"],"gpt_icon":0},{"id":"2459245080","title":"Outlook Therapeutics, Inc.盘中异动 早盘大幅拉升5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459245080","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459245080?lang=zh_cn&edition=full","pubTime":"2024-08-16 23:18","pubTimestamp":1723821513,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日23时18分，Outlook Therapeutics, Inc.股票出现异动，股价急速上涨5.21%。截至发稿，该股报8.08美元/股，成交量7.7682万股，换手率0.33%，振幅7.16%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Cingulate Inc.、Cingulate Inc C/Wts 10/12/2026 、Geovax Labs, Inc.涨幅较大，Cingulate Inc.、Seelos Therapeutics, Inc.、Geovax Labs, Inc.较为活跃，换手率分别为5118.74%、1811.23%、745.25%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Geovax Labs, Inc.、Cingulate Inc.，振幅分别为100.53%、62.68%、53.54%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816231833ab5e17c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816231833ab5e17c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","OTLK"],"gpt_icon":0},{"id":"2459847255","title":"Outlook Therapeutics 公司公布截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2459847255","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459847255?lang=zh_cn&edition=full","pubTime":"2024-08-16 11:48","pubTimestamp":1723780127,"startTime":"0","endTime":"0","summary":"   * Outlook Therapeutics Inc   报告，截至1月底的季度调整后每股亏损83美分，高于去年同期的每股收益1.60美元。七位分析师对该季度的平均预期是每股亏损 1.01 美元。华尔街预期为每股亏损 1.43 美元至-75 美分。* Outlook Therapeutics Inc 公布的季度每股收益为 91 美分。* 公司报告的季度净收入为 4441 万美元。* Outlook Therapeutics Inc 本季度股价下跌了 0.5%，今年迄今为止下跌了 6.9%。华尔街对 Outlook Therapeutics Inc 的 12 个月目标价中位数为 35.00 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OTLK","BK4139","LENZ"],"gpt_icon":0},{"id":"2459082408","title":"Outlook Therapeutics, Inc.盘中异动 股价大涨5.31%报7.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459082408","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459082408?lang=zh_cn&edition=full","pubTime":"2024-08-16 01:09","pubTimestamp":1723741772,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日01时09分，Outlook Therapeutics, Inc.股票出现波动，股价大幅拉升5.31%。截至发稿，该股报7.73美元/股，成交量2.4606万股，换手率0.11%，振幅3.27%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.38%。其相关个股中，Cingulate Inc.、Nutriband Inc C/Wts 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为8413.94%、2282.99%、624.79%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nutriband Inc C/Wts 、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为163.33%、115.79%、103.98%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816010932ab5dddd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816010932ab5dddd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","OTLK","BK4139"],"gpt_icon":0},{"id":"2458543919","title":"Outlook Therapeutics Inc   预计每股亏损1.01美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458543919","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458543919?lang=zh_cn&edition=full","pubTime":"2024-08-10 03:24","pubTimestamp":1723231481,"startTime":"0","endTime":"0","summary":"   * Outlook Therapeutics Inc    将于8月14日公布截至2024年6月30日的财报，预计该公司的季度营收将保持不变。*    * LSEG的分析师平均预计Outlook Therapeutics Inc每股亏损1.01美元。* 华尔街对 Outlook Therapeutics Inc 的 12 个月目标价中位数为 35.00 美元，高于其最新收盘价 7.42 美元。8月9日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","OTLK"],"gpt_icon":0},{"id":"2458403313","title":"Outlook Therapeutics, Inc.盘中异动 下午盘大幅上涨5.06%报7.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458403313","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458403313?lang=zh_cn&edition=full","pubTime":"2024-08-09 01:40","pubTimestamp":1723138824,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日01时40分，Outlook Therapeutics, Inc.股票出现异动，股价快速上涨5.06%。截至发稿，该股报7.37美元/股，成交量9.8934万股，换手率0.42%，振幅6.03%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为3.17%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Senti Biosciences, Inc.、Aldeyra Therapeutics, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Aditxt, Inc.较为活跃，换手率分别为424.56%、296.34%、199.01%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Fibrobiologics, Inc.，振幅分别为131.52%、54.41%、45.58%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809014024aefdf4ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809014024aefdf4ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","OTLK","BK4139"],"gpt_icon":0},{"id":"2457778704","title":"Outlook Therapeutics, Inc.盘中异动 早盘急速下挫5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457778704","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457778704?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:38","pubTimestamp":1722865105,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时38分，Outlook Therapeutics, Inc.股票出现波动，股价急速下挫5.87%。截至发稿，该股报6.90美元/股，成交量1.6659万股，换手率0.07%，振幅0.34%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.94%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Zevra Therapeutics, Inc.、Oculis Holding Ag C/Wts 06/03/2028 涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为1068.42%、51.78%、14.09%，振幅较大的相关个股有Alterity Therapeutics Limited、Cns Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.，振幅分别为20.00%、19.99%、17.59%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213825aefd4c9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213825aefd4c9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","BK4139","LENZ"],"gpt_icon":0},{"id":"2455487969","title":"Outlook Therapeutics, Inc.盘中异动 下午盘大幅下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455487969","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455487969?lang=zh_cn&edition=full","pubTime":"2024-07-31 01:53","pubTimestamp":1722362036,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日01时53分，Outlook Therapeutics, Inc.股票出现异动，股价快速下跌5.13%。截至发稿，该股报7.59美元/股，成交量6.6992万股，换手率0.29%，振幅5.06%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Imunon, Inc.、Celularity Inc C/Wts 16/07/2026 、Pharming Group Nv涨幅较大，Processa Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.、Imunon, Inc.较为活跃，换手率分别为1949.99%、1531.43%、1281.70%，振幅较大的相关个股有Imunon, Inc.、Processa Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.，振幅分别为78.15%、64.12%、59.59%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024073101535696821a6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024073101535696821a6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","BK4139","LENZ"],"gpt_icon":0},{"id":"2453051329","title":"Outlook Therapeutics, Inc.盘中异动 早盘快速上涨5.04%报8.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453051329","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453051329?lang=zh_cn&edition=full","pubTime":"2024-07-23 23:14","pubTimestamp":1721747689,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日23时14分，Outlook Therapeutics, Inc.股票出现波动，股价急速拉升5.04%。截至发稿，该股报8.54美元/股，成交量4.2677万股，换手率0.18%，振幅4.67%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Azitra Inc、Salarius Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc涨幅较大，Salarius Pharmaceuticals, Inc.、Azitra Inc、Adial Pharmaceuticals, Inc较为活跃，换手率分别为5415.54%、4856.25%、3301.90%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Azitra Inc、Adial Pharmaceuticals, Inc，振幅分别为366.13%、365.43%、137.74%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723231449af93ad6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723231449af93ad6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","OTLK","BK4139"],"gpt_icon":0},{"id":"2452438163","title":"Outlook Therapeutics, Inc.盘中异动 早盘股价大跌5.03%报8.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452438163","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452438163?lang=zh_cn&edition=full","pubTime":"2024-07-18 22:53","pubTimestamp":1721314381,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日22时53分，Outlook Therapeutics, Inc.股票出现异动，股价快速下跌5.03%。截至发稿，该股报8.50美元/股，成交量5.4418万股，换手率0.23%，振幅6.48%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.65%。其相关个股中，Onconetix, Inc.、Silo Pharma, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Silo Pharma, Inc.、Onconetix, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为1979.77%、1046.65%、156.40%，振幅较大的相关个股有Silo Pharma, Inc.、Onconetix, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 ，振幅分别为93.33%、86.24%、65.64%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718225301941f85be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718225301941f85be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","BK4139","LENZ"],"gpt_icon":0},{"id":"2451165469","title":"Outlook Therapeutics, Inc.盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451165469","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451165469?lang=zh_cn&edition=full","pubTime":"2024-07-16 22:37","pubTimestamp":1721140622,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日22时37分，Outlook Therapeutics, Inc.股票出现异动，股价快速拉升5.09%。截至发稿，该股报8.88美元/股，成交量5.8873万股，换手率0.25%，振幅3.91%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.07%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Silo Pharma, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2000.82%、1162.94%、288.72%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为61.68%、47.79%、44.12%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716223702af929b0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716223702af929b0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","BK4139","LENZ"],"gpt_icon":0},{"id":"2451091550","title":"Outlook Therapeutics, Inc.盘中异动 临近收盘股价大涨5.01%报8.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451091550","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451091550?lang=zh_cn&edition=full","pubTime":"2024-07-13 03:43","pubTimestamp":1720813390,"startTime":"0","endTime":"0","summary":"北京时间2024年07月13日03时43分，Outlook Therapeutics, Inc.股票出现波动，股价急速拉升5.01%。截至发稿，该股报8.80美元/股，成交量16.775万股，换手率0.72%，振幅6.44%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.66%。其相关个股中，Qualigen Therapeutics, Inc.、Zura Bio Limited C/Wts 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Qualigen Therapeutics, Inc.、Soligenix, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为4172.15%、126.06%、104.16%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Xortx Therapeutics Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为147.88%、78.88%、65.30%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240713034310aef98042&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240713034310aef98042&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","OTLK","BK4139"],"gpt_icon":0},{"id":"2450475968","title":"Outlook Therapeutics, Inc.盘中异动 快速跳水5.19%报7.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450475968","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450475968?lang=zh_cn&edition=full","pubTime":"2024-07-11 03:40","pubTimestamp":1720640443,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日03时40分，Outlook Therapeutics, Inc.股票出现异动，股价急速下跌5.19%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.62%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。消息层面，截至03时40分，《BTIG维持Outlook Therapeutics买入评级，维持目标价50美元》资讯为影响Outlook Therapeutics, Inc.的重要信息。该信息摘要如下：BTIG分析师Julian Harrison维持$Outlook Therapeutics $买入评级，维持目标价50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711034044af91a381&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711034044af91a381&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","OTLK"],"gpt_icon":0},{"id":"2449090567","title":"Outlook Therapeutics, Inc.盘中异动 早盘急速上涨5.05%报7.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449090567","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449090567?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:35","pubTimestamp":1720449344,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时35分，Outlook Therapeutics, Inc.股票出现波动，股价大幅上涨5.05%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Virpax Pharmaceuticals, Inc.、Morphic Holding, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃，换手率分别为2089.69%、171.77%、139.71%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Fortress Biotech Inc 9.375% Cum Red Per Pref Ser A Usd25.00、Cero Therapeutics Holdings, Inc.，振幅分别为93.43%、46.35%、36.60%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708223544aef87ae9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708223544aef87ae9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OTLK","LENZ"],"gpt_icon":0},{"id":"2438512377","title":"Outlook Therapeutics, Inc.盘中异动 早盘急速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438512377","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438512377?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:44","pubTimestamp":1716903842,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时44分，Outlook Therapeutics, Inc.股票出现波动，股价快速跳水5.06%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.50%。其相关个股中，Insmed Incorporated、Calliditas Therapeutics Ab、Exicure, Inc.涨幅较大，Exicure, Inc.、Jaguar Health, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为33.73%、9.31%、7.62%，振幅较大的相关个股有Exicure, Inc.、Insmed Incorporated、Renovaro Inc.，振幅分别为70.52%、20.32%、19.72%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。该信息摘要如下：Outlook Therapeutics Inc——与Cencora建立战略合作伙伴关系以支持Lytenava计划在欧盟商业上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528214403af8ab37f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528214403af8ab37f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","OTLK","BK4139"],"gpt_icon":0},{"id":"2438344376","title":"Outlook Therapeutics Inc——与Cencora（前身为Amerisourcebergen）建立战略合作伙伴关系以支持Lytenava计划在欧盟商业上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2438344376","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438344376?lang=zh_cn&edition=full","pubTime":"2024-05-28 20:17","pubTimestamp":1716898622,"startTime":"0","endTime":"0","summary":"Outlook Therapeutics Inc——与Cencora（前身为Amerisourcebergen）建立战略合作伙伴关系以支持Lytenava计划在欧盟商业上市","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528201704956ec7b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528201704956ec7b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4175","OTLK","BK4529","BK4588","SG9999004303.SGD","LU1585245621.USD","LENZ","BK4585","BK4084","BK4139","COR","SGXZ23171101.USD","LU1430594728.SGD","LU1261432733.SGD"],"gpt_icon":0},{"id":"2438037588","title":"Outlook Therapeutics 获得欧盟委员会用于治疗湿性 AMD 的 Lytenava（贝伐珠单抗 Gamma）的上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2438037588","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438037588?lang=zh_cn&edition=full","pubTime":"2024-05-28 20:16","pubTimestamp":1716898599,"startTime":"0","endTime":"0","summary":"Outlook Therapeutics 获得欧盟委员会用于治疗湿性 AMD 的 Lytenava（贝伐珠单抗 Gamma）的上市许可","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405282016439ef94ad4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405282016439ef94ad4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4141","AMD","GFS","LU0642271901.SGD","IE0004445239.USD","BK4554","LU0889565833.HKD","LU1951198990.SGD","LU1852331112.SGD","LU1064131342.USD","IE00BMPRXN33.USD","BK4534","BK4532","BK4566","BK4588","LU1303367103.USD","LU0109392836.USD","BK4573","LENZ","BK4529","LU1242518931.SGD","LU1989764664.SGD","LU0198837287.USD","LU1951200564.SGD","LU2458330243.SGD","LU1803068979.SGD","LU1923623000.USD","LU1242518857.USD","LU2098885051.SGD","BK4512","LU0082616367.USD","LU1988902786.USD","IE00BMPRXR70.SGD","LU0979878070.USD","LU2264538146.SGD","LU0056508442.USD","BK4575","LU2458330169.SGD","LU1316542783.SGD","LU0127658192.USD","BK4139","LU0719512351.SGD","OTLK","BK4585","IE0009356076.USD"],"gpt_icon":0},{"id":"2436333193","title":"Outlook Therapeutics, Inc.2024财年第一财季实现净利润-1.14亿美元，同比减少1614.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436333193","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2436333193?lang=zh_cn&edition=full","pubTime":"2024-05-20 00:20","pubTimestamp":1716135612,"startTime":"0","endTime":"0","summary":"3月31日，Outlook Therapeutics, Inc.公布财报，公告显示公司2024财年第一财季净利润为-1.14亿美元，同比减少1614.29%；其中营业收入为0.00美元，每股基本收益为-8.01美元。从资产负债表来看，Outlook Therapeutics, Inc.总负债1.93亿美元，其中短期债务44.75百万美元，资产负债比为30.59，流动比率为1.07。机构评级：截至2024年3月31日，当前有7家机构对Outlook Therapeutics, Inc.目标价做出预测，其中目标均价为38.86美元，其中最低目标价为25.00美元，最高目标价为53.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405200020228b186af2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405200020228b186af2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","OTLK"],"gpt_icon":0},{"id":"2435197265","title":"Outlook Therapeutics Inc   预计每股亏损85美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2435197265","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435197265?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:53","pubTimestamp":1715694790,"startTime":"0","endTime":"0","summary":"   * Outlook Therapeutics Inc    将于5月16日公布截至0001年1月1日的财报，预计该公司的季度收入将没有变化。*    * LSEG的分析师平均预计Outlook Therapeutics Inc每股亏损85美分。* 华尔街对 Outlook Therapeutics Inc 的 12 个月目标价中位数为 38.00 美元，高于其最新收盘价 7.54 美元。5月14日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OTLK","LENZ"],"gpt_icon":0},{"id":"2435766613","title":"Outlook Therapeutics, Inc.盘中异动 早盘股价大涨5.15%报7.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435766613","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435766613?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:08","pubTimestamp":1715609308,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时08分，Outlook Therapeutics, Inc.股票出现波动，股价大幅拉升5.15%。截至发稿，该股报7.97美元/股，成交量3.475万股，换手率0.15%，振幅4.88%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.30%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Jasper Therapeutics Inc C/Wts 24/09/2026 、Ac Immune Sa涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为52.06%、27.16%、19.11%，振幅较大的相关个股有Dbv Technologies、Tevogen Bio Holdings Inc.、Azitra Inc，振幅分别为36.84%、35.55%、29.77%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132208297a599c0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132208297a599c0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.outlooktherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.0772},{"period":"3month","weight":-0.0468},{"period":"6month","weight":-0.1416},{"period":"1year","weight":-0.6836},{"period":"ytd","weight":-0.0444}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Outlook Therapeutics, Inc.于2010年1月5日在新泽西州注册成立。该公司是一家临床晚期生物制药公司，致力于开发首个经美国食品和药物管理局（FDA）批准用于视网膜适应症的贝伐单抗眼科制剂。他们直接或通过战略合作伙伴推出贝伐单抗，作为美国、英国、欧洲、日本等市场首个也是唯一批准的贝伐单抗，用于治疗湿性老年性黄斑变性、湿性AMD、糖尿病性黄斑水肿（DME）和视网膜分支静脉阻塞，他们正在就ONS-5010的许可和共同开发权进行积极的后期讨论。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.120556},{"month":2,"riseRate":0.5,"avgChangeRate":0.214631},{"month":3,"riseRate":0.375,"avgChangeRate":-0.032392},{"month":4,"riseRate":0.375,"avgChangeRate":-0.151083},{"month":5,"riseRate":0.625,"avgChangeRate":0.151955},{"month":6,"riseRate":0.375,"avgChangeRate":-0.036511},{"month":7,"riseRate":0.555556,"avgChangeRate":0.021804},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.132986},{"month":9,"riseRate":0.5,"avgChangeRate":0.064501},{"month":10,"riseRate":0.375,"avgChangeRate":0.187824},{"month":11,"riseRate":0.125,"avgChangeRate":-0.10027},{"month":12,"riseRate":0.375,"avgChangeRate":-0.109516}],"exchange":"NASDAQ","name":"Outlook Therapeutics, Inc.","nameEN":"Outlook Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Outlook Therapeutics, Inc.(OTLK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Outlook Therapeutics, Inc.(OTLK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Outlook Therapeutics, Inc.,OTLK,Outlook Therapeutics, Inc.股票,Outlook Therapeutics, Inc.股票老虎,Outlook Therapeutics, Inc.股票老虎国际,Outlook Therapeutics, Inc.行情,Outlook Therapeutics, Inc.股票行情,Outlook Therapeutics, Inc.股价,Outlook Therapeutics, Inc.股市,Outlook Therapeutics, Inc.股票价格,Outlook Therapeutics, Inc.股票交易,Outlook Therapeutics, Inc.股票购买,Outlook Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Outlook Therapeutics, Inc.(OTLK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Outlook Therapeutics, Inc.(OTLK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}